CTNI-21. PIVOTAL, PHASE 2B RENEU TRIAL OF MIRDAMETINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1-ASSOCIATED PLEXIFORM NEUROFIBROMA (NF1-PN): A SPOTLIGHT ON PATIENTS ACHIEVING DEEP RESPONSE

CTNI-21. PIVOTAL, PHASE 2B RENEU TRIAL OF MIRDAMETINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1-ASSOCIATED PLEXIFORM NEUROFIBROMA (NF1-PN): A SPOTLIGHT ON PATIENTS ACHIEVING DEEP RESPONSE

Saved in:
Bibliographic Details
Published in:Neuro-oncology (Charlottesville, Va.) Vol. 26; no. Supplement_8; p. viii100
Main Authors: Gershon, Timothy, Moertel, Christopher, McNall-Knapp, Rene, Shuhaiber, Hans, Weintraub, Lauren, Hajjar, Fouad, Nickerson, Molly, Weber, Michael, Lokku, Armend, Babovic-Vuksanovic, Dusica, Hirbe, Angela
Format: Journal Article
Language:English
Published: 11-11-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/noae165.0388